[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2820 Enrolled Bill (ENR)]

        H.R.2820

                     One Hundred Fourteenth Congress

                                 of the

                        United States of America


                          AT THE FIRST SESSION

          Begun and held at the City of Washington on Tuesday,
           the sixth day of January, two thousand and fifteen


                                 An Act


 
 To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and 
                           for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
    This Act may be cited as the ``Stem Cell Therapeutic and Research 
Reauthorization Act of 2015''.
SEC. 2. REAUTHORIZATION OF THE C.W. BILL YOUNG CELL TRANSPLANTATION 
PROGRAM.
    (a) In General.--Section 379(d)(2)(B) of the Public Health Service 
Act (42 U.S.C. 274k(d)(2)(B)) is amended--
        (1) by striking ``remote collection'' and inserting 
    ``collection''; and
        (2) by inserting ``including remote collection,'' after ``cord 
    blood units,''.
    (b) Authorization of Appropriations.--Section 379B of the Public 
Health Service Act (42 U.S.C. 274m) is amended--
        (1) by striking ``$30,000,000 for each of fiscal years 2011 
    through 2014 and''; and
        (2) by inserting ``and $30,000,000 for each of fiscal years 
    2016 through 2020'' before the period at the end.
    (c) Secretary Review on State of Science.--The Secretary of Health 
and Human Services, in consultation with the Director of the National 
Institutes of Health, the Commissioner of the Food and Drug 
Administration, and the Administrator of the Health Resources and 
Services Administration, including the Advisory Council on Blood Stem 
Cell Transplantation established under section 379(a) of the Public 
Health Service Act (42 U.S.C. 274k(a)), and other stakeholders, where 
appropriate given relevant expertise, shall conduct a review of the 
state of the science of using adult stem cells and birthing tissues to 
develop new types of therapies for patients, for the purpose of 
considering the potential inclusion of such new types of therapies in 
the C.W. Bill Young Cell Transplantation Program (established under 
such section 379) in addition to the continuation of ongoing 
activities. Not later than June 30, 2019, the Secretary shall submit to 
the Committee on Health, Education, Labor, and Pensions of the Senate 
and the Committee on Energy and Commerce of the House of 
Representatives recommendations on the appropriateness of such new 
types of therapies for inclusion in the C.W. Bill Young Cell 
Transplantation Program.
SEC. 3. CORD BLOOD INVENTORY.
    Section 2 of the Stem Cell Therapeutic and Research Act of 2005 (42 
U.S.C. 274k note) is amended--
        (1) in subsection (a), by striking ``one-time'';
        (2) by striking subsection (c);
        (3) by redesignating subsections (d) through (h) as subsections 
    (c) through (g), respectively;
        (4) in subsection (d) (as so redesignated)--
            (A) in paragraph (1), by striking ``paragraphs (2) and 
        (3)'' and inserting ``paragraphs (2), (3), and (4)'';
            (B) in paragraph (2)(B), by striking ``subsection (d)'' and 
        inserting ``subsection (c)''; and
            (C) by adding at the end the following:
        ``(4) Consideration of best science.--The Secretary shall take 
    into consideration the best scientific information available in 
    order to maximize the number of cord blood units available for 
    transplant when entering into contracts under this section, or when 
    extending a period of funding under such a contract under paragraph 
    (2).
        ``(5) Consideration of banked units of cord blood.--In 
    extending contracts pursuant to paragraph (3), and determining new 
    allocation amounts for the next contract period or contract 
    extension for such cord blood bank, the Secretary shall take into 
    account the number of cord blood units banked in the National Cord 
    Blood Inventory by a cord blood bank during the previous contract 
    period, in addition to consideration of the ability of such cord 
    blood bank to increase the collection and maintenance of 
    additional, genetically diverse cord blood units.'';
        (5) in subsection (f) (as so redesignated)--
            (A) by striking paragraph (4); and
            (B) by redesignating paragraphs (5) and (6) as paragraphs 
        (4) and (5), respectively; and
        (6) in subsection (g) (as so redesignated)--
            (A) in paragraph (1)--
                (i) by striking ``$23,000,000 for each of fiscal years 
            2011 through 2014 and''; and
                (ii) by inserting ``and $23,000,000 for each of fiscal 
            years 2016 through 2020'' before the period at the end; and
            (B) by striking paragraph (2).
SEC. 4. DETERMINATION ON THE DEFINITION OF HUMAN ORGAN.
    Not later than one year after the date of enactment of this Act, 
the Secretary of Health and Human Services shall issue determinations 
with respect to the inclusion of peripheral blood stem cells and 
umbilical cord blood in the definition of human organ.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.